sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Stake in Life Science REIT plc
The Vanguard Group, Inc. has released Form 8.3, revealing its public opening positions in Life Science REIT plc. As of February 19, 2026, Vanguard holds 3,269,509 of the 1p ordinary shares in Life Science REIT, representing 0.93% of the relevant securities.
This disclosure is in line with Rule 8.3 of the Takeover Code, necessitating declarations from parties holding an interest of 1% or more in relevant securities. The document also indicates dealings with British Land Company plc in connection with the offer.
Vanguard's latest dealing involved the purchase of 5,620 ordinary shares at £0.43 per unit. No cash or stock-settled derivatives were reported. Furthermore, no indemnities, options, or derivative agreements were noted in relation to Life Science REIT.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.